Gary Murray
Cardiovascular Disease · Germantown, TNNPI 1811965429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $979 and has fallen 76.3% since, to $232 in 2021. That places this record below the midpoint for cardiovascular disease clinicians in TN, where the typical reported total is $1,892.
Across 90 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$236
- Novartis$233
- Lundbeck LLC$116
- Pfizer$98
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$94
- AstraZeneca$88
- plus $697 from 16 others
What the payments were for
- Food & beverage$1,563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 11 | $236 |
| Novartis | 15 | $233 |
| Lundbeck LLC | 6 | $116 |
| Pfizer | 6 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $94 |
| AstraZeneca | 5 | $88 |
| Sanofi-aventis U.S. LLC | 5 | $85 |
| Gilead | 5 | $80 |
| Abbott | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 4 | $69 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| E.r. Squibb & Sons, L.L.C. | 5 | $63 |
| Akcea Therapeutics, Inc. | 3 | $59 |
| Astellas Pharma US Inc | 2 | $48 |
| Amgen | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 2 | $26 |
| Vifor Pharma, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| GE HealthCare | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,563 in reported general payments places this provider in the 45th percentile of 429 cardiovascular disease providers in Tennessee.
Other cardiovascular disease in Germantown
- David MetzgerKingsport$555K
- Christopher EllisNashville$527K
- Joann LindenfeldNashville$270K
- Steven GubinMemphis$248K
- Andrew ZurickNashville$231K
- Mark ZenkerNashville$225K
- Selcuk TombulChattanooga$198K
- George CrossleyNashville$197K
- Joel PharesNashville$171K
- Arvindh KanagasundramNashville$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.